Mockenhaupt Stefan, Grosse Stefanie, Rupp Daniel, Bartenschlager Ralf, Grimm Dirk
Cluster of Excellence CellNetworks, Department of Infectious Diseases, Virology, Heidelberg University Hospital, D-69120 Heidelberg, Germany;
Department of Infectious Diseases, Molecular Virology, Heidelberg University Hospital, D-69120 Heidelberg, Germany; Research Program Infection and Cancer (F170), Division of Virus-Associated Carcinogenesis, German Cancer Research Center, D-69120 Heidelberg, Germany.
Proc Natl Acad Sci U S A. 2015 Jul 28;112(30):E4007-16. doi: 10.1073/pnas.1510476112. Epub 2015 Jul 13.
Exogenous RNAi triggers such as shRNAs ideally exert their activities exclusively via the antisense strand that binds and silences designated target mRNAs. However, in principle, the sense strand also possesses silencing capacity that may contribute to adverse RNAi side effects including off-target gene regulation. Here, we address this concern with a novel strategy that reduces sense strand activity of vector-encoded shRNAs via codelivery of inhibitory tough decoy (TuD) RNAs. Using various shRNAs for proof of concept, we validate that coexpression of TuDs can sequester and inactivate shRNA sense strands in human cells selectively without affecting desired antisense activities from the same shRNAs. Moreover, we show how coexpressed TuDs can alleviate shRNA-mediated perturbation of global gene expression by specifically de-repressing off-target transcripts carrying seed matches to the shRNA sense strand. Our combination of shRNA and TuD in a single bicistronic gene transfer vector derived from Adeno-associated virus (AAV) enables a wide range of applications, including gene therapies. To this end, we engineered our constructs in a modular fashion and identified simple hairpin design rules permitting adaptation to preexisting or new shRNAs. Finally, we demonstrate the power of our vectors for combinatorial RNAi strategies by showing robust suppression of hepatitis C virus (HCV) with an AAV expressing a bifunctional TuD against an anti-HCV shRNA sense strand and an HCV-related cellular miRNA. The data and tools reported here represent an important step toward the next generation of RNAi triggers with increased specificity and thus ultimately safety in humans.
理想情况下,诸如短发夹RNA(shRNAs)之类的外源性RNA干扰触发因子仅通过与指定靶标信使核糖核酸(mRNAs)结合并使其沉默的反义链发挥作用。然而,原则上,正义链也具有沉默能力,这可能导致包括脱靶基因调控在内的不良RNA干扰副作用。在此,我们采用一种新策略来解决这一问题,即通过共递送抑制性强终止诱饵(TuD)RNAs来降低载体编码shRNAs的正义链活性。我们使用各种shRNAs来验证概念,证实共表达TuDs可以在人类细胞中选择性地隔离并使shRNA正义链失活,而不影响同一shRNAs的预期反义活性。此外,我们展示了共表达的TuDs如何通过特异性解除对携带与shRNA正义链种子匹配的脱靶转录本的抑制,来减轻shRNA介导的全局基因表达扰动。我们将shRNA和TuD组合在一个源自腺相关病毒(AAV)的单顺反子基因转移载体中,实现了包括基因治疗在内的广泛应用。为此,我们以模块化方式构建我们的载体,并确定了简单的发夹设计规则,以允许适应现有的或新的shRNAs。最后,我们通过展示用表达针对抗丙型肝炎病毒(HCV)shRNA正义链和一种HCV相关细胞微小RNA(miRNA)的双功能TuD的AAV对HCV的强力抑制,证明了我们的载体用于组合RNA干扰策略的能力。本文报道的数据和工具代表了朝着具有更高特异性从而最终在人类中实现更高安全性的下一代RNA干扰触发因子迈出的重要一步。